We are live on
!
Find out more
Moderna
MRNA
MRNA
1,015 hedge funds and large institutions have $38.5B invested in Moderna in 2023 Q1 according to their latest regulatory filings, with 110 funds opening new positions, 335 increasing their positions, 391 reducing their positions, and 138 closing their positions.
New
Increased
Maintained
Reduced
Closed
20% more call options, than puts
Call options by funds: $2.24B | Put options by funds: $1.86B
5.9% more ownership
Funds ownership: 64.69% → 70.58% (+5.9%)
5% less funds holding
Funds holding: 1,071 → 1,015 (-56)
14% less capital invested
Capital invested by funds: $44.5B → $38.5B (-$6.04B)
14% less repeat investments, than reductions
Existing positions increased: 335 | Existing positions reduced: 391
20% less first-time investments, than exits
New positions opened: 110 | Existing positions closed: 138
45% less funds holding in top 10
Funds holding in top 10: 33 → 18 (-15)
Holders
1,015
Holders Change
-56
Holders Change %
-5.23%
% of All Funds
16.18%
Holding in Top 10
18
Holding in Top 10 Change
-15
Holding in Top 10 Change %
-45.45%
% of All Funds
0.29%
New
110
Increased
335
Reduced
391
Closed
138
Calls
$2.24B
Puts
$1.86B
Net Calls
+$379M
Net Calls Change
+$46M
Top Buyers
| 1 |
Baillie Gifford & Co
Edinburgh,
United Kingdom
|
+$277M |
| 2 |
Capital International Investors
Los Angeles,
California
|
+$224M |
| 3 |
Envestnet Asset Management
Chicago,
Illinois
|
+$222M |
| 4 |
JP Morgan Chase
New York
|
+$180M |
| 5 |
Morgan Stanley
New York
|
+$126M |
Top Sellers
| 1 |
Pacer Advisors
Malvern,
Pennsylvania
|
-$186M |
| 2 |
T. Rowe Price Associates
Baltimore,
Maryland
|
-$184M |
| 3 |
BlackRock
New York
|
-$169M |
| 4 |
Barclays
London,
United Kingdom
|
-$134M |
| 5 |
Citigroup
New York
|
-$62.7M |
